Skip to main content
Equibles

MARSHALL WACE, LLP

Position in MEDP — Medpace Holdings, Inc.

CIK 1318757 LONDON, X0
Back to MEDP Full portfolio

Position in MEDP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$15,454,494
+$10,723,182 QoQ
Shares Held
29,182
+196.2% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#97
of 693 holders
Holding Since
Dec 2022
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in MEDP Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $832,085,876 across 26 Diagnostics & Research names. MEDP ranks #12 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 WAT
Waters Corp /De/
 581,332 $218,022,752
2 QGEN
Qiagen N.V.
 3,491,480 $136,516,866
3 MTD
Mettler Toledo International Inc/
 76,977 $98,338,886
4 CRL
Charles River Laboratories International, Inc.
 342,995 $77,787,835
5 DGX
Quest Diagnostics Inc
 269,760 $57,175,631
6 IDXX
Idexx Laboratories Inc /De
 93,128 $49,026,303
7 NTRA
Natera, Inc.
 131,663 $35,739,920
8 ICLR
Icon PLC
 175,440 $30,475,681

All Filings in MEDP

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,454,494 29,182
2026-03-31 $4,731,312 9,853
2025-12-31 $25,246,729 44,951
2025-09-30 $3,389,342 6,592
2025-06-30 $304,130 969
2025-03-31 $1,026,500 3,369
2024-12-31 $4,795,407 14,434
2024-03-31 $26,371,999 65,253
2023-12-31 $20,792,848 67,833
2023-09-30 $22,208,647 91,722
2023-06-30 $36,582,934 152,321
2022-12-31 $1,550,593 7,300